| Report ID |
175814 |
| Drug Identification Number |
02491338 |
| Brand name |
METHOTREXATE SUBCUTANEOUS |
| Common or Proper name |
METHOTREXATE SODIUM |
| Company Name |
ACCORD HEALTHCARE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
METHOTREXATE |
| Strength(s) |
17.5MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
SUBCUTANEOUS |
| Packaging size |
1 |
| ATC code |
L04AX |
| ATC description |
IMMUNOSUPPRESSANTS |
| Reason for shortage |
Disruption of the manufacture of the drug. |
| Anticipated start date |
|
| Actual start date |
2022-11-26 |
| Estimated end date |
2023-06-29 |
| Actual end date |
2023-06-29 |
| Shortage status |
Resolved |
| Updated date |
2023-06-30 |
| Company comments |
|
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
